Concepedia

Madeline Polak

MP

Statistics

Publications

14

Citations

498

H-Index

12

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Massachusetts General Hospital

Harvard University

Beth Israel Deaconess Medical Center

Madeline Polak is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer pharmacology.

ORCID

Publications per year

2018–2024

14

Publications

14

A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer

Panagiotis A. Konstantinopoulos, Elizabeth K. Lee, Niya Xiong et al. · Journal of Clinical Oncology · 2022 · 82 citations

, , +17

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer

Panagiotis A. Konstantinopoulos, Allison Gockley, Niya Xiong et al. · JAMA Oncology · 2022 · 71 citations · Full text

, , +17

A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer

Panagiotis A. Konstantinopoulos, Alexandre André Balieiro Anastácio da Costa, D. Gulhan et al. · Nature Communications · 2021 · 68 citations · Full text

, , +17

A randomised trial of a web-based physical activity self-management intervention in COPD

Stephanie A. Robinson, John A. Cooper, Rebekah L. Goldstein et al. · ERJ Open Research · 2021 · 49 citations · Full text

, , +17

Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations

Emily S. Wan, Ana Kantorowski, Madeline Polak et al. · Respiratory Medicine · 2020 · 48 citations · Full text

, , +14

1–5 of 14